BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34957573)

  • 1. Heterogeneity in the Identification of Potential Drug-Drug Interactions in the Intensive Care Unit: A Systematic Review, Critical Appraisal, and Reporting Recommendations.
    Bakker T; Dongelmans DA; Nabovati E; Eslami S; de Keizer NF; Abu-Hanna A; Klopotowska JE
    J Clin Pharmacol; 2022 Jun; 62(6):706-720. PubMed ID: 34957573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of potential drug-drug interactions in medical intensive care unit patients.
    Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
    Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
    Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
    J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequency and nature of drug-drug interactions in the intensive care unit.
    Askari M; Eslami S; Louws M; Wierenga PC; Dongelmans DA; Kuiper RA; Abu-Hanna A
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):430-7. PubMed ID: 23420793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug-drug interactions in ICU patients: a retrospective study.
    Ali I; Bazzar A; Hussein N; Sahhar E
    Drug Metab Pers Ther; 2020 Jul; 35(3):. PubMed ID: 32681774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ICU-tailored drug-drug interaction alerts on medication prescribing and monitoring: protocol for a cluster randomized stepped-wedge trial.
    Bakker T; Klopotowska JE; Eslami S; de Lange DW; van Marum R; van der Sijs H; de Jonge E; Dongelmans DA; de Keizer NF; Abu-Hanna A
    BMC Med Inform Decis Mak; 2019 Aug; 19(1):159. PubMed ID: 31409338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
    Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
    Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study.
    Bakker T; Abu-Hanna A; Dongelmans DA; Vermeijden WJ; Bosman RJ; de Lange DW; Klopotowska JE; de Keizer NF; ; Hendriks S; Ten Cate J; Schutte PF; van Balen D; Duyvendak M; Karakus A; Sigtermans M; Kuck EM; Hunfeld NGM; van der Sijs H; de Feiter PW; Wils EJ; Spronk PE; van Kan HJM; van der Steen MS; Purmer IM; Bosma BE; Kieft H; van Marum RJ; de Jonge E; Beishuizen A; Movig K; Mulder F; Franssen EJF; van den Bergh WM; Bult W; Hoeksema M; Wesselink E
    J Crit Care; 2021 Apr; 62():124-130. PubMed ID: 33352505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey.
    Grizzle AJ; Horn J; Collins C; Schneider J; Malone DC; Stottlemyer B; Boyce RD
    J Med Internet Res; 2019 Jan; 21(1):e11182. PubMed ID: 30609981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
    Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
    Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
    Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
    Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Potential Drug-Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-Analysis.
    Fitzmaurice MG; Wong A; Akerberg H; Avramovska S; Smithburger PL; Buckley MS; Kane-Gill SL
    Drug Saf; 2019 Sep; 42(9):1035-1044. PubMed ID: 31098917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis.
    Dornquast C; Dombrowski M; Zabel M; Willich SN; Reinhold T
    BMC Health Serv Res; 2020 Mar; 20(1):271. PubMed ID: 32234046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical decision support systems differ in their ability to identify clinically relevant drug interactions of immunosuppressants in kidney transplant patients.
    Amkreutz J; Koch A; Buendgens L; Trautwein C; Eisert A
    J Clin Pharm Ther; 2017 Jun; 42(3):276-285. PubMed ID: 28224645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of drug-drug interaction in the ICU - perceptions of intensivists and pharmacists.
    Askari M; Eslami S; Louws M; Dongelmans D; Wierenga P; Kuiper R; Abu-Hanna A
    Stud Health Technol Inform; 2012; 180():716-20. PubMed ID: 22874285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Assessment of Potential Drug-Drug Interactions in Intensive Care Unit Patients.
    Wagh BR; Godbole DD; Deshmukh SS; Iyer S; Deshpande PR
    Indian J Crit Care Med; 2019 Apr; 23(4):170-174. PubMed ID: 31130787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of potential drug-drug interactions in intensive care unit.
    Dagdelen MS; Gulen D; Ceylan I; Girgin NK
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5801-5806. PubMed ID: 34604971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-drug interactions in the intensive care unit: Do they really matter?
    Vanham D; Spinewine A; Hantson P; Wittebole X; Wouters D; Sneyers B
    J Crit Care; 2017 Apr; 38():97-103. PubMed ID: 27883969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases.
    Hecker M; Frahm N; Bachmann P; Debus JL; Haker MC; Mashhadiakbar P; Langhorst SE; Baldt J; Streckenbach B; Heidler F; Zettl UK
    Front Pharmacol; 2022; 13():946351. PubMed ID: 36034780
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and nature of potential drug-drug interactions among kidney transplant patients in a German intensive care unit.
    Amkreutz J; Koch A; Buendgens L; Muehlfeld A; Trautwein C; Eisert A
    Int J Clin Pharm; 2017 Oct; 39(5):1128-1139. PubMed ID: 28823018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.